« Back to Record
Citation APA

Marchand, M., Van Baren, N., Weynants, P., Brichard, V., Brasseur, F., van der Bruggen, P., Boon, T., Coulie, P. G., Humblet, Y., Bourlond, A., Vanwijck, R., Dreno, B., Tessier, M. H., Rankin, E., Parmiani, G., Arienti, F., Lienard, D., Beauduin, M., Dietrich, P. Y., Russo, V., Kerger, J., Masucci, G., Jäger, E., De Greve, J., & Atzpodien, J. (1999). Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. International journal of cancer, 80(2), 219-230. doi:10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/181620

Marchand, M., Van Baren, N., Weynants, P., Brichard, V., Brasseur, F., van der Bruggen, P., Boon, T., Coulie, P. G., Humblet, Y., Bourlond, A., Vanwijck, R., Dreno, B., Tessier, M. H., Rankin, E., Parmiani, G., Arienti, F., Lienard, D., Beauduin, M., Dietrich, P. Y., Russo, V., Kerger, J., Masucci, G., Jäger, E., De Greve, J., & Atzpodien, J. (1999). Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. International journal of cancer, 80(2), 219-230. doi:10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S